2012 ISPE Pharmaceutical Supply Chain EU Conference

Back to Basics: Transforming the Pharmaceutical Supply Chain European Conference

22-23 October 2012 - Berlin, Germany

Pharmaceutical Supply Chain is defined as the management of product supply from raw material sourcing to active ingredient manufacturing through formulation, packaging and distribution to the patient. It encompasses all related activities across the product lifecycle including clinical supply, scale-up and transfer as well as outsourcing and product discontinuation. A key requirement is the safe and reliable supply of quality medicines through a supply chain which is responsive to true demand and understands the voice of the customer.

This conference will provide insight into many of the critical-to-success factors in pharmaceutical supply chains. It will focus on how the industry can achieve world-class performance levels and transparency in the end-to-end networks - with a better understanding of how to deliver value to all stakeholders to which the pharmaceutical supply chain industry relates.

The conference will achieve this by combining examples of best practices both within the industry as well as from other relevant sectors. It is also intended to include latest updates and perspectives from regulatory authorities.

Conference Sessions will address :

• Entering a New Era of Supply Chain
• Lessons from Non-Pharma Industries
• Anti-counterfeiting and Supply Chain Integrity
  
  Please click here ( 1 MB) to download the event brochure
  

High-Level Industry and Regulatory Speakers will provide Insights on:

The Implications of the New EU Falsified Medicines Directive on Supply Chain
Richard Andrews, GDP Operations Manager, MHRA

Learning from Other Industries – A Case Study on Capacity Sharing in Pharma
Aeneas Marxen, PhD, Consultant, PharmaCentaur

Setting the Scene for Supply Chain Transformation
Roddy Martin, Senior Vice President Global Supply Chain, Competitive Capabilities International, Inc.

Other Eminent Speakers will include:

• Ali Afnan, PhD, President, Step Change Pharma
• Heike Falkenhagen, PhD, Head of Global Quality Services, Boehringer Ingelheim
• Jim McKiernan, CEO, McKiernan Associates
• Alex Viehmann, Operations Research Analyst at FDA, CDER, Office of Pharmaceutical Science

The Conference will provide:

• Best Practices from within and outside the Pharmaceutical Industry
• Latest Regulatory Updates and Perspectives
• Interactive Workshop Sessions
• Practical Case Studies
• Expert Panel Discussion